Cargando…

Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy

Immunotherapy for cancer is a rapidly developing treatment that modifies the immune system and enhances the antitumor immune response. B7-H3 (CD276), a member of the B7 family that plays an immunoregulatory role in the T cell response, has been highlighted as a novel potential target for cancer immu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Binghao, Li, Huanzhang, Xia, Yu, Wang, Yaning, Wang, Yuekun, Shi, Yixin, Xing, Hao, Qu, Tian, Wang, Yu, Ma, Wenbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597993/ https://www.ncbi.nlm.nih.gov/pubmed/36284349 http://dx.doi.org/10.1186/s13045-022-01364-7

Ejemplares similares

Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma
por: Zhao, Binghao, et al.
Publicado: (2023)

Investigation of Genetic Determinants of Glioma Immune Phenotype by Integrative Immunogenomic Scale Analysis
por: Zhao, Binghao, et al.
Publicado: (2021)

B7-H3 in Brain Malignancies: Immunology and Immunotherapy
por: Guo, Xiaopeng, et al.
Publicado: (2023)

Molecular landscape of IDH-mutant astrocytoma and oligodendroglioma grade 2 indicate tumor purity as an underlying genomic factor
por: Zhao, Binghao, et al.
Publicado: (2022)

Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients
por: Wang, Zihao, et al.
Publicado: (2021)

Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses
por: Zhao, Binghao, et al.
Publicado: (2020)

Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors
por: Chen, Wenlin, et al.
Publicado: (2023)

Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors
por: Guo, Xiaopeng, et al.
Publicado: (2023)

Novel insight into histological and molecular astrocytoma, IDH‐mutant, Grade 4 by the updated WHO classification of central nervous system tumors
por: Chen, Wenlin, et al.
Publicado: (2023)

Comprehensive ability evaluation and trend analysis of patients with malignant intracranial tumors in the perisurgery period
por: Wang, Yaning, et al.
Publicado: (2021)

Prognostic Value of Choline and Other Metabolites Measured Using (1)H-Magnetic Resonance Spectroscopy in Gliomas: A Meta-Analysis and Systemic Review
por: Shi, Yixin, et al.
Publicado: (2022)

Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress
por: Wang, Yaning, et al.
Publicado: (2021)

Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy
por: Zhang, Wenxiang, et al.
Publicado: (2021)

Prognostic Prediction Model for Glioblastoma: A Metabolic Gene Signature and Independent External Validation
por: Lei, Chuxiang, et al.
Publicado: (2021)

Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors
por: Guo, Xiaopeng, et al.
Publicado: (2023)

Characteristic analysis and identification of novel molecular biomarkers in elderly glioblastoma patients using the 2021 WHO Classification of Central Nervous System Tumors
por: Wang, Yaning, et al.
Publicado: (2023)

Palliative care for patients with glioma: A recent scientometric analysis of the Web of Science in 2022
por: Xiao, Zhiyuan, et al.
Publicado: (2022)

Classification of pediatric gliomas based on immunological profiling: implications for immunotherapy strategies
por: Wang, Zihao, et al.
Publicado: (2020)

Optimal Therapies for Recurrent Glioblastoma: A Bayesian Network Meta-Analysis
por: Chen, Wenlin, et al.
Publicado: (2021)

Immune checkpoint signaling and cancer immunotherapy
por: He, Xing, et al.
Publicado: (2020)

Development of a nomogram for prognostic prediction of lower‐grade glioma based on alternative splicing signatures
por: Wang, Yaning, et al.
Publicado: (2020)

Cancer Immunotherapy: A Focus on the Regulation of Immune Checkpoints
por: Shi, Tao, et al.
Publicado: (2018)

Immune Checkpoint Molecules in Reproductive Immunology
por: Miko, Eva, et al.
Publicado: (2019)

Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy
por: Li, Guan-Zhang, et al.
Publicado: (2019)

Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
por: Cao, Yuqing, et al.
Publicado: (2020)

Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of Glioblastoma
por: Yeo, Alan T., et al.
Publicado: (2023)

Immune-Mediated Hepatitis During Immune Checkpoint Inhibitor cancer Immunotherapy: Lessons From Autoimmune Hepatitis and Liver Immunology
por: Hercun, Julian, et al.
Publicado: (2022)

A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade Immunotherapy
por: Yang, Jing, et al.
Publicado: (2022)

Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy
por: Khan, Muhammad, et al.
Publicado: (2021)

Response Prediction in Immune Checkpoint Inhibitor Immunotherapy for Advanced Hepatocellular Carcinoma
por: Hung, Hao-Chien, et al.
Publicado: (2021)

Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
por: Voeller, Julie, et al.
Publicado: (2019)

Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy
por: Chuckran, Christopher A, et al.
Publicado: (2020)

Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker–based immunotherapy
por: Wang, Feihu, et al.
Publicado: (2020)

Associating resistance to immune checkpoint inhibitors with immunological escape in colorectal cancer
por: Ding, Yi, et al.
Publicado: (2022)

Immune checkpoints and immunotherapy for colorectal cancer
por: Singh, Preet Paul, et al.
Publicado: (2015)

Diversity of immune checkpoints in cancer immunotherapy
por: Guo, Zhangyan, et al.
Publicado: (2023)

B7-H3, a checkpoint molecule, as a target for cancer immunotherapy
por: Yang, Shuo, et al.
Publicado: (2020)

Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma
por: Ho, Won Jin, et al.
Publicado: (2020)

Identifying immune checkpoint-related lncRNA biomarkers for immunotherapy response and prognosis in cancers
por: Gao, Yue, et al.
Publicado: (2023)

Nanobodies targeting immune checkpoint molecules for tumor immunotherapy and immunoimaging (Review)
por: Yu, Sheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a3ljnfnhtqs4r13fqdqqht4p3u